This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke recovery is a challenging process that extends for months after hospital discharge. To improve outcomes and be in compliance with new regulations, it's crucial to better identify and address these issues during the recovery period. After the stroke, I had new prescriptions, and this was the first obstacle for me.
years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 The primary focus was on 5-year survival rates. for SAVR vs. 0.4%
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8
We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.
Stroke, Ahead of Print. BACKGROUND:Patient-reported outcome measures (PROMs) describe health status from the perspective of the patient. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain.
Stroke, Volume 55, Issue Suppl_1 , Page ATP83-ATP83, February 1, 2024. Background:The success of post-stroke rehabilitation depends on the cooperation of many components such as: severity of the stroke, speed with which treatment begins, skills of the rehabilitation team, cooperation of the survivor with family and friends.
Stroke, Ahead of Print. BACKGROUND:Endovascular therapy (EVT) has been proven effective for patients with acute ischemic stroke with large infarcts. The primary outcome was the ordinal 90-day modified Rankin Scale score (0, no symptoms, to 6, death).RESULTS:Among
Stroke, Ahead of Print. BACKGROUND:Stroke survivors with impaired balance and motor function tend to have relatively poor functional outcomes. The cerebellum and primary motor cortex (M1) have been suggested as targets for neuromodulation of balance and motor recovery after stroke. points ([95% CI, 2.7–18.6],P=0.009)
BackgroundRacial and ethnic minority groups are at a higher stroke risk and have poor poststroke outcomes. Trials conducted in the United States, related to stroke and enrolling participants ≥18 years, were considered eligible. fold increase in reporting between 2010 and 2020. Overall, 60.1% were of Hispanic ethnicity.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOver the past decade, stroke management has significantly improved with the widespread use of intravenous thrombolysis (IVT) and the establishment of endovascular thrombectomy (EVT) as the standard of care for increasing patients.
The answer is pretty simple, but most people get this wrong, and doing so increases their future risk of heart attack and strokes. Outcome over process, in my view, works best here. 2020 Apr;16(4):223-237. ” This is one of the most common questions I get as a cardiologist. There are others also. Nat Rev Nephrol.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. BackgroundIt is unclear whether all patient subgroups with acute ischemic stroke have benefited from advances in reperfusion therapy. Secular changes were assessed per 5‐year cohorts (2000–2005, 2006–2010, 2011–2015, 2016–2020). to 29.8%.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP60-AWMP60, February 1, 2024. However, limited information exists on how demographic and clinical factors are associated with social inequities among older patients hospitalized with acute ischemic stroke (AIS) during COVID-19.Methods:We All patients were followed until March 31, 2023.
Stroke, Volume 55, Issue Suppl_1 , Page A52-A52, February 1, 2024. Background/Purpose:Stroke imposes a substantial healthcare burden, with ischemic stroke (IS) mortality rising from 2.04 We compared demographics, hospital traits, comorbidities, and outcomes. million (1990) to 3.29 million (2019) and projected to reach 4.90
Stroke, Volume 55, Issue Suppl_1 , Page AWP203-AWP203, February 1, 2024. A total of 4353 patients who underwent endovascular treatment for acute ischemic stroke between January 2016 and December 2020 were included in the study. Results:Of the 4353 patients included in the study, 1520 patients (34.9%) achieved good outcome.
Stroke, Volume 56, Issue Suppl_1 , Page AWP209-AWP209, February 1, 2025. This study examines how COVID-19 affects functional outcomes of ischemic stroke patients.Methods:Ischemic stroke patients admitted to our Joint Commission-certified primary stroke center were retrospectively analyzed from March 1, 2020, to March 1, 2022.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP90-ATMP90, February 1, 2025. Somatization, a third internalizing subscale in the BASC questionnaire, was also included in the analysis.Results:AIS patients (N=161, 98 male; median age and range at stroke 1.9 years [0 13.8 SD= 8.7), Anxiety (mean= 76.6, and Somatization (mean= 81.9,
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOptimal triage strategies for patients suspected of acute ischemic stroke due to large vessel occlusion remains debated. Outcomes were compared for EVT hospitalizations with direct vs transferred presentation at discharge.
Methods From January 2018 to December 2020, 947 patients with mitral valve surgery in our department were selected. Results There were no significant difference in the long-term mortality, long-term risk of stroke and reoperation. These patients were divided into 3 groups according to the starting time of surgery.
Stroke, Volume 56, Issue Suppl_1 , Page AHUP1-AHUP1, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and strokeoutcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among
Stroke, Volume 56, Issue Suppl_1 , Page ADP53-ADP53, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and strokeoutcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among
Designed to improve productivity and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. The faster stroke is treated, the better the potential outcome.
Stroke, Volume 56, Issue Suppl_1 , Page AWP268-AWP268, February 1, 2025. Introduction:The overall composition of stroke subtype is typically stable within biogeographical groups. Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States.
Stroke, Volume 55, Issue Suppl_1 , Page ATP203-ATP203, February 1, 2024. Introduction:The outcomes of endovascular thrombectomy (EVT) in SARS-CoV2 positive patients with acute ischemic stroke (AIS) are not well studied. Temporal analyses compared outcomes across the years 2020-2022.Results:A
Stroke, Volume 56, Issue Suppl_1 , Page AWP162-AWP162, February 1, 2025. Introduction:Outpatient follow-up within thirty days of discharge home after an ischemic stroke is associated with reduced readmission rates. Clinical demographics, follow-up with either a non-neurology care provider (e.g., days and 77.5
This study aimed to assess whether statin use could lead to better outcomes among individuals with AF.Methods and ResultsWe enrolled 397 787 patients with AF from January 1, 2012 to December 31, 2020. We analyzed 288 958 patients with newly diagnosed AF (mean age, 73 years; 44% women; mean CHA2DS2VASc score, 3.5).
Stroke, Volume 56, Issue Suppl_1 , Page AWP155-AWP155, February 1, 2025. Background:Cancer-related stroke (CRS) is a rare condition where a tumor or its metastasis can compress a blood vessel and result in stroke. Patients were divided into those with strokes (ischemic or hemorrhagic) and those without strokes.
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDIn 2019 and 2020, 2 randomized trials of basilar artery occlusion (BAO) thrombectomy reported no improvement in functional outcomes with thrombectomy, despite observational evidence and weak guidelines recommending thrombectomy. versus 16.1%;P=0.41).
Stroke, Volume 55, Issue Suppl_1 , Page A79-A79, February 1, 2024. Background:Stroke outcomes may be changing over time with improved acute stroke therapy, secondary prevention, and post-acute care. At the same time, stroke mortality has declined suggesting more people are living with stroke disability.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2024. Objectives:To determine the relationship between patient-reported outcome measures (PROMs) and volumetric biomarkers assessed on clinical imaging in acute ischemic stroke (AIS).Background:AIS Background:AIS is a leading cause of long-term disability.
Patients and methods From December 2009 to June 2020, 388 elective patients were included in our retrospective study. Inverse probability of treatment weighting (IPTW) was used to adjust for selection bias and to estimate treatment effects on short- and long-term outcomes. vs. n = 30/8.0%, p = 0.012), fewer transfusions (0.93
Stroke, Volume 55, Issue Suppl_1 , Page ATP261-ATP261, February 1, 2024. Introduction:There are several pathogenic mechanisms that have been theorized for cocaine-related ischemic strokes (CRIS). The majority of patients had intracranial atherosclerotic disease (62.2%) on imaging and in the area of the stroke (55.4%).
Stroke, Volume 56, Issue Suppl_1 , Page ATP270-ATP270, February 1, 2025. Introduction:Syphilis is associated with increased risk of cerebrovascular disease and acute stroke; stroke may even be the initial clinical manifestation of syphilis (Images 1 and 2). between 2016-2019, but then dropped to 1.02% in 2020.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2025. We compared demographics, radiological findings, clinical outcomes, and follow-up results between mismatch and no mismatch groups.Results:Among 73 patients, 20 (27.4%) had DWI-ADC mismatch. DWIR% = (DWIR/baseline DWI volume) 100 was calculated. ml/h vs. 7.5
Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. S-COVID had lower successful recanalization (74.9% versus 85.6%;P<0.001),
Stroke, Volume 56, Issue Suppl_1 , Page AWMP28-AWMP28, February 1, 2025. The hospitals were groups into quartiles based on the volume of MT procedures performed within the calendar year.
Stroke, Volume 55, Issue Suppl_1 , Page AWP31-AWP31, February 1, 2024. Background:Tenecteplase (TNK) has been reported to be non-inferior to alteplase from a clinical outcome and safety standpoint according to recent studies. A nonsignificant decrease in the odds of symptomatic intracranial hemorrhage (sICH) was seen with TNK.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP45-AWMP45, February 1, 2025. Home time is a valid measure of functional recovery in stroke patients that is often used in outcome studies. Home time is a valid measure of functional recovery in stroke patients that is often used in outcome studies.
Stroke, Volume 55, Issue Suppl_1 , Page ATP269-ATP269, February 1, 2024. The association between AF and IS outcomes differed by IS therapy (Table 1). female, 56.2% Black), 26.2% received IVtPA, 45.8% MT, and 27.9% AF patients had an increased odds of a worse mRS (Ordinal OR 2.05, 95% CI 1.14-3.71), respectively).
Stroke: Vascular and Interventional Neurology, Ahead of Print. We included the outcomes of our trial in an aggregate data meta‐analysis of randomized‐controlled clinical trials evaluating the utility of BP control after successful EVT. participants/month).
Twelve-month outcomes data from the pilot phase of the admIRE study, which assessed the safety and efficacy of the VARIPULSE Platform among U.S. Pulsed Field Ablation Using a Variable Loop Circular Catheter with 3D Mapping Integration: Early Outcomes of the admIRE Study [abstract]. Int J Stroke. Epub 2020 Jan 19.
Stroke, Volume 55, Issue Suppl_1 , Page ATP123-ATP123, February 1, 2024. Background:Hospitals with higher procedure volume are more likely to have lower rates of death or disability, with most neurovascular surgical and endovascular procedures.
BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods
We reported the feasibility and short-term outcomes of percutaneous transcatheter therapy with cerebral embolic protection. During the follow-up, 12.50% (n=3) all-cause death, 4.17% (n=1) stroke, and 16.67% (n=4) recurrence were seen. 1273.47) days, stroke was 1211.38 (95% CI, 1110.40–1312.35)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content